Oncosil Financial Statements From 2010 to 2026

Stocks . Australia . 
Stock . Oncosil Medical
OSL Stock   0.97  0.01  1.02%   
Analyzing historical trends in various income statement and balance sheet accounts from Oncosil Medical's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Oncosil Medical's valuation are summarized below:
Gross Profit
-718.4 K
Market Capitalization
18.3 M
Enterprise Value Revenue
11.3476
Revenue
1.5 M
Earnings Share
(1.38)
There are currently eighty-six trending fundamental ratios for Oncosil Medical that can be evaluated and compared over time across competitors. All traders should check out Oncosil Medical's recent fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction.

Oncosil Medical Total Revenue

1.42 Million

Check Oncosil Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oncosil Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 30.6 K, Interest Expense of 789 or Selling General Administrative of 9.1 M, as well as many indicators such as . Oncosil financial statements analysis is a perfect complement when working with Oncosil Medical Valuation or Volatility modules.
  
This module can also supplement various Oncosil Medical Technical models . Check out the analysis of Oncosil Medical Correlation against competitors.

Oncosil Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets10.2 M8.2 M10.7 M
Pretty Stable
Other Current Liabilities2.4 M2.3 M799.4 K
Slightly volatile
Total Current Liabilities4.9 M4.6 M1.7 M
Slightly volatile
Total Stockholder Equity3.4 M3.6 M8.8 M
Very volatile
Property Plant And Equipment Net211.2 K381.9 K181 K
Slightly volatile
Accounts Payable2.3 M2.2 M863.3 K
Slightly volatile
Cash6.7 M5.9 M7.6 M
Slightly volatile
Non Current Assets Total362.8 K381.9 K347.2 K
Very volatile
Cash And Short Term Investments7.3 M5.9 M8.3 M
Pretty Stable
Common Stock Total Equity84.7 M80.7 M49.1 M
Slightly volatile
Common Stock Shares Outstanding11.9 M12.6 M593.5 M
Slightly volatile
Liabilities And Stockholders Equity10.4 M8.2 M10.8 M
Pretty Stable
Other Current Assets373.5 K471.1 K456.4 K
Very volatile
Total Liabilities4.9 M4.7 M1.8 M
Slightly volatile
Property Plant And Equipment Gross341.7 K675.3 K260.8 K
Slightly volatile
Total Current Assets9 M7.7 M10.2 M
Pretty Stable
Common Stock116.4 M110.9 M57 M
Slightly volatile
Short and Long Term Debt Total59.8 K62.9 K166.4 K
Slightly volatile
Other Liabilities2.6 K2.7 K27 K
Slightly volatile
Long Term Debt236.4 K169.2 K202.4 K
Slightly volatile
Net Receivables1.4 M1.4 M1.5 M
Pretty Stable
Good Will1.3 M810 K974.9 K
Pretty Stable
Intangible Assets2.3 M3 M2.6 M
Slightly volatile
Property Plant Equipment222.2 K381.9 K244.9 K
Pretty Stable
Net Tangible Assets13.7 M11.4 M11.7 M
Pretty Stable
Other Assets0.860.9707
Slightly volatile
Net Invested Capital2.7 M2.8 M9.9 M
Slightly volatile
Cash And Equivalents8.2 M6.9 M8.2 M
Pretty Stable
Net Working Capital2.3 M2.4 M9.7 M
Slightly volatile
Capital Stock85.8 M110.9 M68.3 M
Slightly volatile
Capital Lease Obligations59.8 K62.9 K121 K
Pretty Stable
Short and Long Term Debt21.3 K23.9 K26.1 K
Slightly volatile

Oncosil Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization30.6 K32.2 K54.1 K
Slightly volatile
Selling General Administrative9.1 M8.7 M3.7 M
Slightly volatile
Other Operating Expenses20.1 M19.2 M10 M
Slightly volatile
Total Operating Expenses17.4 M16.6 M8.6 M
Slightly volatile
Total Revenue1.4 M1.1 M1.6 M
Pretty Stable
Research Development2.8 M4.8 M2.9 M
Slightly volatile
Cost Of Revenue2.7 M2.6 M791 K
Slightly volatile
Selling And Marketing Expenses249.4 K262.5 K2 M
Slightly volatile
Interest Income56.5 K81.8 K112.3 K
Slightly volatile
Reconciled Depreciation39 K41.1 K67.9 K
Slightly volatile

Oncosil Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation94.3 K50.6 K59.5 K
Slightly volatile
Capital Expenditures12.8 K13.5 K40 K
Pretty Stable
Total Cash From Financing Activities15.4 M14.6 M9.2 M
Slightly volatile
End Period Cash Flow6.7 M5.9 M7.6 M
Slightly volatile
Dividends Paid13.3 M15 M16.4 M
Slightly volatile
Issuance Of Capital Stock7.6 M11.5 M14.6 M
Slightly volatile

Oncosil Fundamental Market Drivers

About Oncosil Medical Financial Statements

Oncosil Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Oncosil Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Oncosil Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Oncosil Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue 0.90  0.95 
Total Revenue1.1 M1.4 M
Cost Of Revenue2.6 M2.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Oncosil Stock Analysis

When running Oncosil Medical's price analysis, check to measure Oncosil Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncosil Medical is operating at the current time. Most of Oncosil Medical's value examination focuses on studying past and present price action to predict the probability of Oncosil Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncosil Medical's price. Additionally, you may evaluate how the addition of Oncosil Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY